Roeker, Lindsey E. http://orcid.org/0000-0002-3806-059X
Knorr, David A. http://orcid.org/0000-0002-0766-8914
Thompson, Meghan C.
Nivar, Mariely
Lebowitz, Sonia
Peters, Nicole
Deonarine, Isaac Jr
Momotaj, Saddia
Sharan, Saumya
Chanlatte, Vanessa
Hampton, Bianca
Butala, Liana
Amato, Lindsay
Richford, Angela
Lunkenheimer, Jessica
Battiato, Kristen
Laudati, Carissa
Mato, Anthony R.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748, P30 CA008748)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 2 April 2021
Revised: 21 April 2021
Accepted: 27 April 2021
First Online: 13 May 2021
Compliance with ethical standards
:
: LER has served as a consultant for AbbVie, AstraZeneca, Pharmacyclics, Vaniam group, and Verastem, holds minority ownership interest in Abbott Laboratories, and has received research funding (paid to the institution) from Pfizer and Aptose Biosciences outside of the submitted work. DAK receives research support on COVID-19 from Pfizer. MCT has received honoraria from MJH Life Sciences, VJ Heme Onc, Curio Science. KB has consulted for AbbVie and Janssen. ARM has served as a consultant and received research funding from Curio Science, TG Therapeutics, Celgene, Janssen; AbbVie, Adaptive, Loxo, Nurix, Genmab, Genentech, Pfizer, Octopharma, Pharmacyclics, AstraZeneca, Sunesis, DTRM, Gilead, and Johnson & Johnson. He served as DSMB member at TG Therapeutics. All other authors declare no competing interest.
Free to read: This content has been made available to all.